Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.

Steffen Pfeiffer; George L Zorn; Jian-Ping Zhang; Todd D Giorgio; Simon C Robson; Agnes M Azimzadeh; Richard N Pierson

doi:10.1097/01.TP.0000058517.07194.90

Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.

Steffen Pfeiffer, George L Zorn, Jian-Ping Zhang, Todd D Giorgio, Simon C Robson, Agnes M Azimzadeh, Richard N Pierson

Department of Cardiac Surgery

Research output: Contribution to journal › Original Article › peer-review

27 Citations (Web of Science)

Original language	English
Pages (from-to)	953-959
Journal	TRANSPLANTATION
Volume	75
Issue number	7
DOIs	https://doi.org/10.1097/01.TP.0000058517.07194.90
Publication status	Published - 2003

Keywords

AURIN TRICARBOXYLIC-ACID
WILLEBRAND-FACTOR BINDING
HUMAN BLOOD
AURINTRICARBOXYLIC ACID
XENOGRAFT REJECTION
ANTIBODIES
HEART
SURVIVAL
REMOVAL
COLUMN

Access to Document

10.1097/01.TP.0000058517.07194.90

Cite this

Pfeiffer, S., Zorn, G. L., Zhang, J.-P., Giorgio, T. D., Robson, S. C., Azimzadeh, A. M., & Pierson, R. N. (2003). Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. TRANSPLANTATION , 75(7), 953-959. https://doi.org/10.1097/01.TP.0000058517.07194.90

Pfeiffer, Steffen ; Zorn, George L ; Zhang, Jian-Ping et al. / Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. In: TRANSPLANTATION 2003 ; Vol. 75, No. 7. pp. 953-959.

@article{c76689ef1ea64fd28139d7aa251dc0d4,

title = "Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.",

keywords = "AURIN TRICARBOXYLIC-ACID, WILLEBRAND-FACTOR BINDING, HUMAN BLOOD, AURINTRICARBOXYLIC ACID, XENOGRAFT REJECTION, ANTIBODIES, HEART, SURVIVAL, REMOVAL, COLUMN",

author = "Steffen Pfeiffer and Zorn, {George L} and Jian-Ping Zhang and Giorgio, {Todd D} and Robson, {Simon C} and Azimzadeh, {Agnes M} and Pierson, {Richard N}",

year = "2003",

doi = "10.1097/01.TP.0000058517.07194.90",

language = "English",

volume = "75",

pages = "953--959",

journal = "TRANSPLANTATION ",

issn = "0041-1337",

number = "7",

}

Pfeiffer, S, Zorn, GL, Zhang, J-P, Giorgio, TD, Robson, SC, Azimzadeh, AM & Pierson, RN 2003, 'Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.', TRANSPLANTATION , vol. 75, no. 7, pp. 953-959. https://doi.org/10.1097/01.TP.0000058517.07194.90

Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. / Pfeiffer, Steffen; Zorn, George L; Zhang, Jian-Ping et al.
In: TRANSPLANTATION , Vol. 75, No. 7, 2003, p. 953-959.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.

AU - Pfeiffer, Steffen

AU - Zorn, George L

AU - Zhang, Jian-Ping

AU - Giorgio, Todd D

AU - Robson, Simon C

AU - Azimzadeh, Agnes M

AU - Pierson, Richard N

PY - 2003

Y1 - 2003

KW - AURIN TRICARBOXYLIC-ACID

KW - WILLEBRAND-FACTOR BINDING

KW - HUMAN BLOOD

KW - AURINTRICARBOXYLIC ACID

KW - XENOGRAFT REJECTION

KW - ANTIBODIES

KW - HEART

KW - SURVIVAL

KW - REMOVAL

KW - COLUMN

U2 - 10.1097/01.TP.0000058517.07194.90

DO - 10.1097/01.TP.0000058517.07194.90

M3 - Original Article

C2 - 12698079

SN - 0041-1337

VL - 75

SP - 953

EP - 959

JO - TRANSPLANTATION

JF - TRANSPLANTATION

IS - 7

ER -

Pfeiffer S, Zorn GL, Zhang JP, Giorgio TD, Robson SC, Azimzadeh AM et al. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. TRANSPLANTATION . 2003;75(7):953-959. doi: 10.1097/01.TP.0000058517.07194.90